Perrigo Company plc Payments to Acquire Additional Interest in Subsidiaries
Perrigo Company plc (PRGO) reported Payments to Acquire Additional Interest in Subsidiaries of $0 for the 9-month period ending 2015-03-28, per its 10-Q filed 2015-04-29.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries · last filed 2015-04-29
- Perrigo Company plc payments to acquire additional interest in subsidiaries for the quarter ending 2015-03-28 was $0.00.
- Perrigo Company plc payments to acquire additional interest in subsidiaries for the quarter ending 2014-06-28 was $0.00.
- Perrigo Company plc payments to acquire additional interest in subsidiaries for the quarter ending 2014-03-29 was $0.00.
- Perrigo Company plc payments to acquire additional interest in subsidiaries for the quarter ending 2013-06-29 was $0.00.
- Perrigo Company plc payments to acquire additional interest in subsidiaries for fiscal 2014 was $7.20M.
- Perrigo Company plc payments to acquire additional interest in subsidiaries for fiscal 2013 was $0.00.
- Perrigo Company plc payments to acquire additional interest in subsidiaries for fiscal 2012 was $0.00.
| Period end | Payments to Acquire Additional Interest in Subsidiaries 3 month | Payments to Acquire Additional Interest in Subsidiaries 6 month | Payments to Acquire Additional Interest in Subsidiaries 9 month | Payments to Acquire Additional Interest in Subsidiaries 12 month |
|---|---|---|---|---|
| 2015-03-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-29 | $0.00 10-Q · filed 2015-04-29 | ||
| 2014-12-27 | $0.00 10-Q · filed 2015-02-05 | |||
| 2014-06-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-14 | $0.00 derived: sum of 2 quarters · filed 2015-04-29 | $7.20M 10-K · filed 2014-08-14 | |
| 2014-03-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-29 | $7.20M 10-Q · filed 2015-04-29 | ||
| 2013-12-28 | $7.20M 10-Q · filed 2015-02-05 | |||
| 2013-06-29 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-14 | $0.00 derived: sum of 2 quarters · filed 2014-08-14 | $0.00 10-K · filed 2014-08-14 | |
| 2013-03-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-07 | $0.00 10-Q · filed 2014-05-07 | ||
| 2012-12-29 | $0.00 10-Q · filed 2014-02-06 | |||
| 2012-06-30 | $0.00 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |